MEDAPIA

This brand name is authorized in Spain, Lithuania, Malta

Active ingredients

The drug MEDAPIA contains one active pharmaceutical ingredient (API):

1 Entacapone UNII 4975G9NM6T - ENTACAPONE

Entacapone belongs to a new therapeutic class, catechol-O-methyl transferase (COMT) inhibitors. It is a reversible, specific, and mainly peripherally acting COMT inhibitor designed for concomitant administration with levodopa preparations. Entacapone prolongs the clinical response to levodopa. Read about Entacapone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MEDAPIA Film-coated tablet	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N04BX02	Entacapone	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BX Other dopaminergic agents
Discover more medicines within N04BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 82845
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1084719, 1084720, 1084721, 1084722, 1084723, 1084724
Country: MT	Medicines Authority	Identifier(s): MA032/13201